Reston, VA—Nearly 70 percent of breast cancer patients could find out if their cancer has spread to their lymph nodes without having to undergo an invasive sentinel node biopsy. New research published ...

Please provide your email address to receive an email when new articles are posted on . Sentinel lymph node biopsy was effective as a prognostic and staging tool in stage IIB/C melanoma, according to ...

THE etiology of a pleural effusion can at times be difficult to establish. Pulmonary tuberculosis and bronchogenic carcinoma are notorious in this regard, and in both diseases it is mandatory that ...

A recent prospective study sought to identify the subgroup of melanoma patients (based on age and tumor thickness) in which the risk of nodal metastasis is low and who may avoid routine SLN biopsy.

Barcelona, Spain: Using an ultrasound-guided fine needle to biopsy lymph nodes could spare thousands of melanoma patients every year worldwide from having to undergo unnecessary and sometimes ...

SAN ANTONIO -- Patients with early breast cancer who skipped axillary lymph node dissection (ALND) lived just as long as those who underwent sentinel lymph node biopsy (SLNB), the randomized INSEMA ...

SCINCE its introduction by Daniels 1 in 1949 the technic of prescalene-lymph-node biopsy has gained favor as a means of studying intrathoracic disease. The simplicity of the method has permitted its ...

The primary way to diagnose lymphoma involves a lymph node biopsy. However, doctors may utilize several other diagnostic procedures depending on a person’s lymphoma. Doctors can use blood tests, ...

Results from the PHENIX-I trial support skipping pelvic lymphadenectomy in women with early cervical cancer who have a negative sentinel lymph node biopsy. Omitting pelvic lymphadenectomy in these ...

Skipping standard axillary lymph node dissection led to very low rates of axillary recurrence in patients with node-positive breast cancer who became node-negative following neoadjuvant chemotherapy, ...

Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...